Entheon Biomedical Corp. (CSE:ENBI)

Canada flag Canada · Delayed Price · Currency is CAD
0.0800
+0.0100 (14.29%)
Oct 9, 2025, 1:08 PM EDT
14.29%
Market Cap1.11M
Revenue (ttm)n/a
Net Income (ttm)-342.81K
Shares Out13.86M
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume20,000
Average Volume4,793
Open0.0800
Previous Close0.0700
Day's Range0.0800 - 0.0800
52-Week Range0.0700 - 0.3800
Beta1.42
RSI30.13
Earnings DateOct 24, 2025

About Entheon Biomedical

Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Timothy Ko
Employees 1
Stock Exchange Canadian Securities Exchange
Ticker Symbol ENBI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.